Top News
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
SBA Member, 16.06.2018
ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018
SBA Member, 15.06.2018
Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients' quality of life
SBA Member, 15.06.2018
Novartis study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer
SBA Member, 15.06.2018
Novartis presents data to advance understanding of the role of IL-17A and reinforce Cosentyx® leadership in spondyloarthritis
SBA Member, 13.06.2018
Memo Therapeutics AG appoints Dr. Karsten Fischer as Chief Executive Officer
SBA Member, 13.06.2018
Santhera Submits NDA in South Korea for Raxone® for the Treatment of LHON
SBA Member, 12.06.2018
Idorsia initiates a Phase 3 registration program with nemorexant (ACT-541468) for the treatment of insomnia
SBA Member, 11.06.2018
Partners
Supported by:
